Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Teva Japan Names CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Teva Japan Names CEO

Kikushige brings 30 years of industry experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ichiro Kikushige has been appointed chief executive officer of Teva Seiyaku, Japan, effective on May 15, 2013. Mr. Kikushige will replace Makoto Shimada, who is retiring after serving 40 years in Japan’s pharma industry. Mr. Shimada will stay with the company until June 30, 2013 to facilitate a smooth transition.
 
“As an effective leader with more than 30 years of experience in the pharmaceutical industry, Mr. Kikushige is well-qualified to assume this important role within Teva in Japan,” said Prof. Itzhak Krinsky, chairman of Teva Japan and Teva South Korea. “Under the leadership of Teva president and chief executive officer Dr. Jeremy Levin, the company is implementing a new growth strategy to become the most indispensable pharmaceutical company of the world. Japan, the second largest pharmaceutical market, offers attractive opportunities for growth, and we now are entering into the next phase of leveraging our established business and position within the Japanese market.”
 
Mr. Kikushige is currently head of sales at Eli Lilly Japan. He joined Lilly in 1988 as a sales representative and was promoted to marketing director in 1997, head of the Oncology Business in 2002, and has held his current position since 2008. Before joining Lilly, he worked for Pfizer Japan and has more than 30 years of pharmaceutical industry experience.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters